Respiratory Muscle Function Changes and Effects of Chest Physiotherapy Education Interventionin Advanced Lung Cancer
The Impact of Changes in Respiratory Muscle Function on Dyspnea, Functional Capacity, and Quality of Life in Patients With Advanced Lung Cancer & the Effects of Chest Physiotherapy Education Intervention
1 other identifier
interventional
102
1 country
1
Brief Summary
The purpose for the 1st phase of this study are to exam longitudinal changes and the impact of various treatments on the respiratory muscle function, and the relations with dyspnea, functional capacity, quality of life, 6- and 12-month respiratory morbidity, and survival status (control group). The 2nd phase of this study will investigate the potential beneficial effects of chest physiotherapy in the same patient population (intervention group).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable lung-cancer
Started Aug 2010
Typical duration for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2010
CompletedStudy Start
First participant enrolled
August 1, 2010
CompletedFirst Posted
Study publicly available on registry
December 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedDecember 6, 2012
November 1, 2012
3 years
March 16, 2010
December 4, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Numbers of upper respiratory infections (URI) and respiratory infection related hospitalizations
Numbers of URIs and respiratory infection related hospitalizations were collected from out-patient and inpatient medical records.
12 months after study entry
Secondary Outcomes (2)
Funcional capacity Anxiety/depression symptom Quality of life Six- and 12-month respiratory complication morbidity and survival status
every 3 months up to 18 months post study entry
Dyspnea and QoL
every 3 months up to 18 months
Study Arms (1)
Control
NO INTERVENTIONInterventions
breathing exercise (diaphragmatic breathing and pursed-lip breathing cough training secretion mobilization (percussion and vibration) progressive muscle relaxation pacing and energy-saving techniques
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of stage III/V lung cancer
- Normal cognition (a Mini Mental State Examination score of more than/equal to 24 points)
- Able to finish all tests
You may not qualify if:
- A clinical diagnosis affecting respiratory muscle function and functional activity performance (e.g. musculoskeletal disorders)
- Unable to perform acceptable-quality spirometry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Li-Ying Wang, Ph.D.
School and Graduate Institute of Physical Therapy, National Taiwan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2010
First Posted
December 6, 2012
Study Start
August 1, 2010
Primary Completion
August 1, 2013
Study Completion
August 1, 2013
Last Updated
December 6, 2012
Record last verified: 2012-11